E3 ubiquitin ligase MID1 ubiquitinates and degrades type‐I interferon receptor 2

Author:

Chen Xiangjie1,Zhao Qian12,Xu Ying34,Wu Qiuyu1,Zhang Renxia12,Du Qian1,Miao Ying1,Zuo Yibo1,Zhang Hong‐Guang1,Huang Fan1,Ren Tengfei1,He Jiuyi1,Qiao Caixia1,Li Yue2,Li Shifeng3,Xu Yang5,Wu Depei5,Yu Zhengyuan6,Lv Haitao7,Wang Jun3,Zheng Hui1ORCID,Yuan Yukang1ORCID

Affiliation:

1. Institutes of Biology and Medical Sciences, Jiangsu Key Laboratory of Infection and Immunity Soochow University Suzhou China

2. School of Biology and Basic Medical Sciences Soochow University Suzhou China

3. Department of Intensive Care Medicine, the First Affiliated Hospital of Soochow University Soochow University Suzhou China

4. Department of Intensive Care Unit Qinghai Provincial People's Hospital Xining China

5. National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, the First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology Soochow University Suzhou China

6. Department of Oncology The First Affiliated Hospital of Soochow University Suzhou China

7. Department of Cardiology Children's Hospital of Soochow University Suzhou China

Funder

National Key Research and Development Program of China

National Natural Science Foundation of China

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3